戻る Agenda
Session 3 – Part II: Update on International Activities and Collaboration – Focus on Africa
Session Chair(s)
Shahinaz Badr, PharmD
Pharmacovigilance Consultant and PVQA Auditor - EMEA
Independent Consultant, United Arab Emirates
Elspeth McIntosh, MBA, RN
Director
Castle Pharmacovigilance Ltd, United Kingdom
This year's session will focus on international cooperation and joint collaboration between national and regional regulators, as well as international organizations. As examples we will look at the role of the Bill & Melinda Gates Foundation in advancing patient safety in Africa, hear updates on the development of the African Medicines Agency and learn more about the development of the QPPV role in an individual African country.
Speaker(s)
Updates on the African Medicines Agency
Chimwemwe Chamdimba
African Union Development Agency-NEPAD, South Africa
Principal Programme Officer-African Medicines Regulatory Harmonisation Program
EFDA: Ethiopia's Initiative on Training QPPVs
Demeke Amare
Ethiopian Food and Drug Authority (EFDA), Ethiopia
Pharmacovigilance and Clinical Trial expert
Deirdre McCarthy, MSc
Gates Foundation, United States
Pharmacovigilance Lead, Regulatory System Strengthening